Researchers identify promising new compound to treat tuberculosis Study led by Scripps Research, Texas A&M and additional institutions highlights that the world's deadliest infectious disease needs novel, effective antibiotics.
August 07, 2025
LA JOLLA, CA Scientists have developed a new compound that could offer a breakthrough in the global fight against tuberculosis, history's deadliest infectious disease.
A study recently published in Nature on July 30, 2025, describes the treatment potential of the novel compound known as CMX410. The drug uniquely targets a crucial enzyme in Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. Importantly, this compound even proved effective against drug-resistant infections, which are common globally and pose a significant challenge for controlling the disease's spread and progression.
The study was led by James Sacchettini, Ph.D., the Rodger J. Wolfe-Welch Foundation Chair in Science, Texas A&M AgriLife Research scientist and professor in the Texas A&M College of Agriculture and Life Sciences Department of Biochemistry and Biophysics. He was joined by Case McNamara, Ph.D., senior director of infectious disease at Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research dedicated to accelerating next-generation medicines.
The discovery was made possible through collaborations formed by the TB Drug Accelerator program, an initiative funded by The Gates Foundation to support research focused on developing the most promising tuberculosis treatments.
A lot of people think of tuberculosis as a disease of the past, Sacchettini said. But in reality, it remains a major public health issue requiring significant attention, collaboration and innovation to overcome.
A smarter way to fight back
The new compound identified by AgriLife Research and Calibr-Skaggs works by blocking a crucial enzyme, polyketide synthase 13 or Pks13, that M. tuberculosis needs to build its protective cell wall. Without the functionality of this protein, the bacteria can't survive to cause infection.
For over a decade, scientists have recognized this protein as a high-value target in the fight against tuberculosis. Yet, despite its potential, drug development efforts have repeatedly fallen short largely because compounds must clear a high bar for both safety and therapeutic performance.
The unique mechanism of CMX410 makes it highly specific for its target, which translates to a favorable safety profile. By incorporating a reactive chemical group that forms an irreversible bond with a critical site on Pks13, the researchers enhanced the compound's selectivity, minimizing potentially negative off-target effects. This modification also reduces the likelihood of resistance emerging.
The addition of this key chemical group was accomplished with click chemistry, a method that snaps molecules together like puzzle pieces. Click chemistry was developed by co-author Barry Sharpless, Ph.D., W.M. Keck Professor of Chemistry at Scripps Research and two-time Nobel Laureate, and it has led to the development of extensive libraries of chemical compounds.
This technique represents a new tool for drug design, said McNamara. We expect to see its uses expand in the coming years to help address public health concerns with a critical need, including tuberculosis.
Early results prove safe and effective
The team began by investigating a library of compounds shared by the Sharpless lab to identify molecules that could inhibit bacterial growth of M. tuberculosis.
After intensive optimization to improve compound potency and other pharmacological properties led by Calibr-Skaggs tuberculosis team members and co-first authors Baiyuan Yang, Ph.D., associate director of medicinal chemistry, and Paridhi Sukheja, Ph.D., investigator of infectious diseases, CMX410 was identified as a strong contender.
Yang, who led the chemistry optimization, said the team explored more than 300 analogs to identify a compound with the right balance of potency, selectivity and safety. The team ultimately tested CMX410 against 66 strains of M. tuberculosis and found that it worked on both laboratory and multidrug-resistant strains collected from real patients.
Identifying this novel target was an exciting moment, said Sukheja, who led many early studies showing CMX410 could target a previously unexplored gene. It opened up a completely new path forward, especially against strains that have learned to evade existing treatments.
In other early experiments, the researchers determined that CMX410 could be safely combined with other tuberculosis antibiotics. This was an especially important factor for this disease, as treatment regimens require multiple drugs to be taken together for months at a time.
Researchers found no adverse effects in their initial tests in animal models even at the maximum dose level. And because CMX410 is highly specific to its target protein, they see it as unlikely to disrupt other beneficial bacteria or cause broader microbiome imbalances, a common side effect of conventional antibiotics.
Progress toward better treatments
The addition of a specialized chemical group that allows CMX410 to irreversibly bind to its target makes the compound extremely selective. These types of inhibitors remain an exciting and underexplored class of drugs, and further research will be needed to confirm their safety for humans.
Nonetheless, the precision, unique mechanism, good safety profile and other key features all make CMX410 a promising candidate for treating tuberculosis.
These early results are very encouraging, said Inna Krieger, Ph.D., senior research scientist in Sacchettini's lab and co-first author of the study. Cell wall-targeting antibiotics have long been a cornerstone of tuberculosis trea
Most recent headlines
06/10/2025
France T l visions, France's leading broadcaster, has received the 2025 EBU ...
04/09/2025
Monumental Sports & Entertainment (MSE), in collaboration with Dalet, has been a...
11/08/2025
11 08 2025 - Media release Screen Australia celebrates emerging creatives and cu...
09/08/2025
WASHINGTON Federal Communications Commission Chair Brendan Carr announced the ap...
09/08/2025
ATLANTA CBS Stations has announced the senior leadership team for WUPA, soon to rebrand as owned-and-operated station CBS Atlanta. The network affiliation chang...
09/08/2025
A new study from S&P Global Market Intelligence Kagan is forecasting rapid advertising growth for Amazon's streaming efforts....
08/08/2025
(L-R) Amy Berg, Mary Guibert, and Ben Harper attend the 2025 Sundance Film Festival It's Not Over, Jeff Buckley premiere The Ray Theatre. (Photo by Robin ...
08/08/2025
ATLANTA Following an announcement in June that Byron Allen's Allen Media Group planned to sell its TV stations, Gray Media struck a deal to acquire AMG'...
08/08/2025
WASHINGTON Federal Communications Commission Chair Brendan Carr announced the ap...
08/08/2025
NEW YORK and LOS ANGELES Fox has finally announced a launch data and pricing for Fox One, with the direct-to-consumer streaming service set to launch Aug. 21 fo...
08/08/2025
PLYMOUTH, Wis. Heartland Video Systems has announced that they've signed a reseller agreement with Cuez for the company's all-in-one rundown/news room c...
08/08/2025
Grass Valley, the pioneering media and entertainment technology innovator, is bringing the full power of the Grass Valley Media Universe (GVMU) to IBC 2025 with...
08/08/2025
Alfalite, the only European manufacturer of LED screens, announces the successful inauguration of a new Virtual Production XR studio at the ITS Apulia Foundatio...
08/08/2025
The Scottish Rite Childhood Language Center (SRCLC), a nonprofit clinic dedicated to supporting children with communication disorders, has significantly upgrade...
08/08/2025
European developer Profuz Digital will present at IBC Stand 8.A88, the latest version of subtitling platform SubtitleNEXT and new capabilities in the powerful A...
08/08/2025
Disguise has announced a major update to its AI-powered workflow assistant for Designer Pro, Ask AId3n. The update enables production teams to sequence repetiti...
08/08/2025
Wyandotte Municipal Services (WMS), a municipal non-profit service provider, has successfully deployed Synamedia Gravity, a cloud-based device management and se...
08/08/2025
IBC2025 has unveiled a powerful and provocative IBC2025 Conference line-up that will bring together global disruptors and long-established leaders from across t...
08/08/2025
Evergent (#5.A86), the leader in customer management and monetization for streaming and digital subscription businesses, will debut a suite of new solutions to ...
08/08/2025
Humans Not Robots (HNR), a pioneering provider of sustainable media technology solutions, is delighted to announce its participation in IBC2025. At the leading ...
08/08/2025
As Little League Softball World Series Popularity Grows, So Too Does ESPN's ...
08/08/2025
Levi's Stadium Facelift, Part 1: Full Glass-to-Glass 4K, IP-Based Control Ro...
08/08/2025
Levi's Stadium Facelift, Part 2: NFL's Largest 4K Videoboards, LED Sport...
08/08/2025
Levi's Stadium Facelift, Part 3: ANC's Jerry Cifarelli Jr. on Growing th...
08/08/2025
Levi's Stadium Facelift, Part 4: Under the Lights' Event Culminates Mul...
08/08/2025
The Hills Are Alive: A Year at Kylemore Abbey starts Sunday at 6.30pm on RT One and RT Player
The Hills Are Alive: A Year at Kylemore Abbey, a new RT obser...
08/08/2025
Kieran's last C il House will be live from Fleadh Cheoil na h ireann this Saturday August 9
After three decades at the helm of RT Radio 1's C il Hou...
08/08/2025
Researchers identify promising new compound to treat tuberculosis Study led by Scripps Research, Texas A&M and additional institutions highlights that the world...
07/08/2025
By Jessica Herndon
In writer-director Marielle Heller's feature debut, The ...
07/08/2025
Increasing uncertainty about the future development of global trade, tariff incr...
07/08/2025
A bold new sporting documentary series celebrating First Nations athletes, cultu...
07/08/2025
L3Harris delivered three AEPS thrusters to NASA Glenn Research Center for testing. AEPS thrusters are capable of accelerating spacecraft to extremely high speed...
07/08/2025
Rendering of NTS-3 Navigational Satellite over North America...
07/08/2025
There are two ecosystems coexisting in entertainment: one for millennials and younger; another for Gen X and older, so says media universe cartographer Evan S...
07/08/2025
Berklee City Music Students Receive Scholarships, Awards at Concert This year, 17 students received scholarships, housing awards, and aid to attend Berklee Co...
07/08/2025
WASHINGTON Broadcast Management Group (BMG) has announced plans to open two new full-scale broadcast studios in the nation's capital, filling a long-standin...
07/08/2025
NEW YORK Nielsen and WPP Media have announced a new agreement for audience measurement spanning TV, streaming, audio, and cross-platform ad performance via Niel...
07/08/2025
BRISTOL, Conn. In a long-awaited move that could have a major impact on the pay TV ecosystem, ESPN said it will launch its previously announced direct-to-consum...
07/08/2025
MONTREAL Haivision Systems Inc. has announced that it will slowcase its latest tech advances in live video contribution at IBC2025 from September 12-15 at Hall ...
07/08/2025
PARIS Ateme has announced that it is powering a nationwide terrestrial service upgrade for KT Skylife, a South Korean satellite television provider....
07/08/2025
WASHINGTON Following an Executive Order issued by President Donald Trump that appointed Federal Communications Commission Chair Brandan Carr to a White House Ta...
07/08/2025
The Trusted Partner Network (TPN), the Motion Picture Association's (MPA) global content security initiative, today announced the upcoming launch of its nex...
07/08/2025
07 Aug 2025
VEON 2Q25 Earnings Release: Direct Digital Revenues Up 57% YoY. Sol...
07/08/2025
NBC Olympics Tech Guru Darryl Jefferson to Receive SMPTE's David Sarnoff Med...
07/08/2025
Tennis Channel's Broadcast Feat: One Day, Two Tournaments, Four Cities Two ATP Masters 1000 tourneys will be aired today By Mark J Burns, SVG Contributor
...
07/08/2025
The World Games 2025: ISB Shares Bold Production Plans for 12th Edition of the M...
07/08/2025
SVG Summit, SVGW Australia Event Expand SVG's Presence Down Under By SVG Staff
Thursday, August 7, 2025 - 1:47 pm
Print This Story | Subscribe
Story...
07/08/2025
The CW, FOX Nation Saddle Up for PBR Camping World Team Series Broadcast, streamed coverage is designed to spur fanbase expansion By Jason Dachman, Editorial D...
07/08/2025
RT has today announced the appointment of Mark Simpson to the role of Managing Editor, RT Radio 1.
Reporting to the Head of RT Radio 1, Tara Campbell, Mark ...
Researchers identify promising new compound to treat tuberculosis Study led by Scripps Research, Texas A&M and additional institutions highlights that the world's deadliest infectious disease needs novel, effective antibiotics.
